According to The Insight Partners, the medical writing market size is projected to reach US$ 9,114.91 million by 2031 from US$ 3,931.50 million in 2023. The market is expected to register a CAGR of 11.1% during 2023–2031. The implementation of artificial intelligence (AI) in medical writing is likely to introduce new trends in the market during the coming years. AI-enabled tools can support document generation, content organization, data interpretation, and quality checks while allowing professional medical writers to retain oversight of scientific accuracy and regulatory compliance. The growing importance of medical writing in obtaining regulatory approvals, increasing preference for CROs, and rising demand for regulatory and clinical trial documentation are key factors supporting market growth.
Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00008502
Medical Writing Market Size, Share, Trends, Analysis, and Forecast by 2031
- Market Size: The global medical writing market is projected to reach US$ 9,114.91 million by 2031, compared with US$ 3,931.50 million in 2023.
- Market Growth: The market is expected to expand at a CAGR of 11.1% from 2023 to 2031.
- Regional Share: North America held the leading position, accounting for 33.9% market share in 2023.
- US Growth: The US medical writing market is projected to register a CAGR of 11.4% during the forecast period.
- Type Analysis: Clinical writing represented the largest type segment, accounting for 44.5% of the market in 2023, while regulatory writing is expected to record the highest CAGR through 2031.
- Application Analysis: Medical journalism held the largest share by application in 2023 and is anticipated to register the fastest growth, with a projected 11.3% CAGR.
- End-User Analysis: Pharmaceutical and biotechnology companies dominated the market in 2023, accounting for 70.7% of the market, and are expected to continue providing significant growth opportunities.
- Technology Trend: AI-enabled medical writing solutions are emerging as an important market trend, supporting faster content creation and documentation workflows while maintaining human oversight.
- Key Growth Driver: Increasing regulatory complexity and the importance of accurate documentation for drug and medical product approvals are driving demand for professional medical writing.
- Future Opportunity: Growing clinical research, personalized medicine, biologics, gene therapies, cell-based therapies, and digital health platforms are expected to create new opportunities for medical writing service providers.
Medical Writing Market Trends and Growth Analysis
One of the prominent trends shaping the medical writing market is the increasing integration of artificial intelligence and digital technologies into documentation workflows. AI can assist writers with repetitive activities, document structuring, information retrieval, and preliminary content generation. However, human expertise remains important for interpreting scientific evidence, ensuring contextual accuracy, maintaining consistency, and meeting regulatory expectations. The combination of AI-based tools and professional medical writing expertise is therefore likely to influence service delivery models through 2031.
Another important growth factor is the rising demand for regulatory and clinical trial documentation. Pharmaceutical and biotechnology companies must prepare extensive documentation throughout drug development, from clinical trial protocols and study reports to regulatory submissions and product information. As drug development becomes more complex and regulatory expectations continue to evolve, companies are increasingly turning to specialized medical writing organizations and CROs. This outsourcing trend enables organizations to access skilled professionals while managing costs and improving documentation timelines.
The increasing development of personalized medicine, biologics, gene therapies, and cell-based therapies is also creating opportunities for specialized medical writers. These therapies involve complex scientific data and require clear documentation for regulatory authorities, healthcare professionals, researchers, and other stakeholders. In parallel, the expansion of digital health, telemedicine, and mobile health platforms is generating demand for medical content that communicates complex healthcare information in an accessible and scientifically accurate manner.
Medical Writing Market Segmentation Analysis
Based on type, the market is segmented into clinical writing, regulatory writing, scientific writing, and others. Clinical writing held the largest market share in 2023, while regulatory writing is expected to demonstrate the highest growth rate during the forecast period. By application, the market is categorized into medical journalism, medical education, medico marketing, and others. Medical journalism held the largest share in 2023 and is expected to register the highest CAGR through 2031. By end user, the market is divided into pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies represented the largest end-user segment in 2023.
Regional Analysis
North America: North America dominated the medical writing market in 2023, supported by regulatory requirements, clinical research activity, and the presence of major pharmaceutical and biotechnology companies. Outsourcing of medical writing activities to specialized service providers is another important factor supporting regional growth.
US: The US is expected to account for the largest country-level market share. Strong clinical trial activity, regulatory documentation requirements, and pharmaceutical and biotechnology industry expansion are fueling demand for medical writing services.
Canada: Canada is supported by its growing life sciences ecosystem, clinical research activities, and demand for regulatory and scientific documentation.
Mexico: Increasing pharmaceutical and healthcare activities and greater integration with North American life sciences supply chains are expected to provide opportunities for medical writing services.
Europe: Europe represents a significant market due to established pharmaceutical and biotechnology industries and stringent regulatory requirements.
Asia Pacific: Asia Pacific is expected to experience strong growth, with the region projected to register an 11.5% CAGR during the forecast period. Expanding pharmaceutical and biotechnology industries, increasing clinical trials, and evolving regulatory requirements are supporting demand.
South and Central America: Growth is supported by increasing healthcare activities and expanding pharmaceutical research and development.
Middle East and Africa: Growing healthcare investments, pharmaceutical development, and improving research infrastructure are expected to create emerging opportunities for medical writing providers.
Medical Writing Market Key Players
- Cactus Communications
- Parexel International Corp
- Certara Inc.
- Freyr LLC
- Quanticate International Ltd
- SIRO Clinpharm Pvt Ltd
- ProPharma Group
- Caidya
- Wipro Ltd
- SGS SA
- Laboratory Corp of America Holdings
- TUNECT
- Indegene Ltd
- Evidera
- Syner-G BioPharma Group
The competitive landscape is evolving as companies introduce technology-enabled services, expand regulatory and clinical writing capabilities, and pursue strategic acquisitions. For example, Certara introduced its CoAuthor regulatory writing software combining generative AI with document templates and structured content authoring tools. Indegene also acquired Trilogy Writing & Consulting GmbH to strengthen its clinical, regulatory, safety, and medical content capabilities.
Get Premium Research Report Market Size and Report at:
https://www.theinsightpartners.com/buy/TIPRE0000850
Future Outlook
The Medical Writing Market is positioned for strong expansion through 2031 as pharmaceutical and biotechnology companies face increasingly complex regulatory requirements and growing volumes of clinical and scientific information. The projected increase from US$ 3,931.50 million in 2023 to US$ 9,114.91 million by 2031, at a CAGR of 11.1%, highlights the significant commercial potential of the industry. North America and the US are expected to remain important growth centers, while AI integration, outsourcing, personalized medicine, advanced therapies, and expanding clinical research are likely to reshape the competitive landscape.
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
